Bruce J. Giantonio

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 2.3K citations

Medicine, Oncology, Pharmacotherapy +15

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina et al. · Nature Medicine · 2019 · 522 citations

Medicine, Oncology, Pathology +16

Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer

Aparna R. Parikh, Emily E. Van Seventer, Giulia Siravegna et al. · Clinical Cancer Research · 2021 · 361 citations · Full text

Medicine, Molecular Medicine, Oncology +17

High-dose bevacizumab improves survival when combined with FOLFOX4 in previously treated advanced colorectal cancer: Results from the Eastern Cooperative Oncology Group (ECOG) study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2005 · 344 citations

Medicine, Oncology, Pharmacotherapy +13

Characteristics Associated With Differences in Survival Among Black and White Women With Breast Cancer

Jeffrey H. Silber, Paul R. Rosenbaum, Amy S. Clark et al. · JAMA · 2013 · 306 citations · Full text

Medicine, Biostatistics, Oncology +17